- ADVERTISEMENT FEATURE Advertiser retains sole responsibility for the content of this article
Novel anti-inflammatory compounds for psoriasis and beyond
Anatabine citrate, a cholinergic small molecule in development at Rock Creek Pharmaceuticals, offers a distinct alternative to existing nonsteroidal anti-inflammatory drugs (NSAIDs), steroids and biologics for the treatment of chronic and acute inflammatory diseases. The company is looking to partner for a phase 2 trial in psoriasis.